By tracking how cells respond to hundreds of thousands of compounds, Soley Therapeutics aims to discover medicines for complex diseases where traditional target-based approaches often fall short.
Bruker has launched Beacon Discovery™, a benchtop system for live single-cell analysis designed for broader use in academic and translational research.